IPX
Closed
Iperionx Limited American Depositary Share
29.51
-1.99 (-6.32%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 31.5
Day's Range: 29.35 - 30.075
Send
sign up or login to leave a comment!
When Written:
5.5
IperionX Limited is a pharmaceutical company based in the Netherlands that focuses on developing innovative therapies for rare diseases. The company's American Depositary Shares (ADS) are traded on the Nasdaq stock exchange under the ticker symbol "IPRX." Each ADS represents one ordinary share of IperionX Limited. As of September 2021, the company had a market capitalization of approximately $1.5 billion. IperionX Limited has a pipeline of drug candidates in various stages of development, including treatments for Huntington's disease, amyotrophic lateral sclerosis (ALS), and other rare neurological disorders. The company's lead candidate, IPRX-1, is currently in phase 2 clinical trials for the treatment of Huntington's disease.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








